simbrinza- brinzolamide/brimonidine tartrate suspension/ drops
alcon laboratories, inc. - brinzolamide (unii: 9451z89515) (brinzolamide - unii:9451z89515), brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brinzolamide 10 mg in 1 ml - simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. simbrinza is contraindicated in patients who are hypersensitive to any component of this product. simbrinza is contraindicated in neonates and infants (under the age of two years) [see use in specific populations (8.4)]. developmental toxicity studies with brinzolamide in rabbits at oral doses of 1, 3, and 6 mg/kg/day (20, 60, and 120 times the recommended human ophthalmic dose) produced maternal toxicity at 6 mg/kg/day and a significant increase in the number of fetal variations, such as accessory skull bones, which was only slightly higher than the historic value at 1 and 6 mg/kg. in rats, statistically decreased body weights of fetuses from dams receiving oral doses of 18 mg/kg/day (180 times the recommended
perfluoropropane cylinder
alcon laboratories australia pty ltd - 44405 - perfluoropropane cylinder - the device is a surgical aid for use in the treatment of uncomplicated retinal detachment by pneumatic retinopexy. it is used in the form of an intravitreal injection for selected retinal breaks and to aid in resorption of subretinal fluid.
posanol suspension
merck canada inc - posaconazole - suspension - 200mg - posaconazole 200mg - azoles
jamp posaconazole suspension
jamp pharma corporation - posaconazole - suspension - 40mg - posaconazole 40mg
definity
ami technologies ltd., israel - peflurten - suspension for injection - peflurten 1.1 mg/ml - other cardiovascular system diagnostic radiopharmaceuticals - echocardiography: definity (perflutren injectable suspension) is indicated for contrast-enhanced ultrasound imaging of cardiac structures (ventricular chambers and endocardial borders) and function (regional wall motion) in adult patients with suboptimal echocardiograms. abdominal ultrasound : definity is also indicated for contrast-enhanced ultrasound imaging of the liver and kidneys in adult patients to improve the evaluation of pathology.
cabenuva suspension (extended-release)
viiv healthcare ulc - cabotegravir; rilpivirine - suspension (extended-release) - 200mg; 300mg - cabotegravir 200mg; rilpivirine 300mg - hiv integrase inhibitors
cabenuva suspension (extended-release)
viiv healthcare ulc - cabotegravir; rilpivirine - suspension (extended-release) - 200mg; 300mg - cabotegravir 200mg; rilpivirine 300mg - hiv integrase inhibitors
fluconazole powder, for suspension
hikma pharmaceuticals usa inc. - fluconazole (unii: 8vzv102jfy) (fluconazole - unii:8vzv102jfy) - fluconazole 10 mg in 1 ml - fluconazole for oral suspension, usp is indicated for the treatment of: prophylaxis: fluconazole is also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy. specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly. fluconazole for oral suspension usp is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. there is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. caution should be used in prescribing fluconazole to patients with hypersensitivity to other azoles. co-administration of te
banzel suspension
eisai limited - rufinamide - suspension - 40mg - rufinamide 40mg - miscellaneous anticonvulsants
alphagan p
abbvie biopharmaceuticals ltd, israel - brimonidine tartrate - ophthalmic solution - brimonidine tartrate 0.15 %w/v - brimonidine - brimonidine - alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.